RAFI HOFSTEIN, PhD, MSc

Dr. Hofstein came to Toronto from Israel in 2009 to assume the position of President & CEO of a newly formed organization called MaRS Innovation (recently renamed as Toronto Innovation Acceleration Partners, TIAP). At this position, Dr. Hofstein led to the creation of over fifty start-up companies primarily in the healthcare space. Among the companies of primary note are Triphase, Fibrocor and Notch Therapeutics in which Dr. Hofstein has been a cofounder and a director. In addition, Dr. Hofstein is a member of the board of several not-for-profit organization in Quebec and Ontario. 

Prior to coming to Canada, Dr. Hofstein served as the President & CEO of Hadasit (the tech transfer company of Hadassah, Jerusalem) and the chairman of Hadasit Bioholding (a holding company listed on the Tel-Aviv Stock Exchange). One of the companies Dr. Hofstein cofounded and joined as a director is BiolineRx, an Israeli biotech company listed on NASDAQ. 

Dr. Hofstein received his Ph.D. from the Weizmann Institute of Science (Rehovot, Israel) and his postdoctoral training at Harvard Medical School. Dr. Hofstein also had a long tenure in the IDF and retired as a colonel after serving in the reserve troops for over twenty years.